Taxotere Approved for Treatment of Metastatic Breast Cancer
June 1998 – Taxotere was approved for first-line treatment of metastatic breast cancer in subjects whose disease had recurred despite adjuvant therapy. Reference: “Taxotere (Docetaxel).” CenterWatch RSS, www.centerwatch.com/directories/1067-fda-approved-drugs/listing/4266-taxotere-docetaxel
Continue Reading